The Nutshell

» disease/medicine and policy

Daily News Roundup

Most Recent

image: Obama’s Plan for a Bioeconomy

Obama’s Plan for a Bioeconomy

By | April 27, 2012

The White House announces a strategy to foster development of biological products in fields ranging from medicine to agriculture.

4 Comments

image: Amgen Founder Dies

Amgen Founder Dies

By | April 25, 2012

George Rathmann, father of the biotech industry, passes away.

2 Comments

image: Gulf Oil Spill Failings

Gulf Oil Spill Failings

By | April 24, 2012

A marine scientist ponders how academics could have handled the 2010 Deepwater Horizon oil spill better.

4 Comments

image: Publish H5N1 Papers, Says US Gov’t

Publish H5N1 Papers, Says US Gov’t

By | April 23, 2012

The NIH agrees with the government advisory board’s recommendation to publish both controversial bird flu studies in full.

0 Comments

image: Congress Supports NIH Budget Increase

Congress Supports NIH Budget Increase

By | April 23, 2012

Petitions asking for more funding for the federal research agency are gaining bipartisan support in both the House and Senate.

2 Comments

image: $44 Million Earmarked for Research

$44 Million Earmarked for Research

By | April 19, 2012

Congress sets aside a large pot of pork-barrel funds for research projects in 2012, but not nearly as much as seen in pre-recession years.

2 Comments

image: White House Weighs in on H5N1

White House Weighs in on H5N1

By | April 18, 2012

Science adviser John Holdren speaks out about how the Presidential Administration is handling the controversial research that rendered avian flu transmissible between ferrets.

0 Comments

image: H5N1 Researcher to Defy Dutch Gov’t?

H5N1 Researcher to Defy Dutch Gov’t?

By | April 18, 2012

A virologist at the center of avian flu research controversy says he’ll publish without government permits.

4 Comments

image: Flu Review Criticized

Flu Review Criticized

By | April 17, 2012

A member of the NSABB biosecurity board that recently reviewed H5N1 data criticizes the process.

4 Comments

image: China’s Black Market Stem Cells

China’s Black Market Stem Cells

By | April 13, 2012

Despite government efforts to ban unapproved stem cell treatments, companies around China still offer them openly.

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

  4. Another DNA Vaccine for Zika Shows Promise
RayBiotech